WFH e-Learning Platform: Discover the Chaotic Science Behind All 13 Clotting Factors
The World Federation of Hemophilia (WFH) recently shared a post on X:
”Did You Know: Many different clotting factors work together in a series of chemical reactions to stop bleeding. Learn more about Bleeding Disorders and how the WFH is working towards Treatment for all.”
An e-learning platform to clear all the chaos of clotting mechanisms!
Clotting factors are essential proteins in the blood that coordinate to stop bleeding after vessel injury—as you may have heard.
When damage occurs, blood vessels constrict, and platelets adhere to the injury site, forming an initial plug.
These activated platelets release signals that recruit more platelets and initiate the coagulation cascade—a series of reactions involving clotting factors on the platelet surface.
This cascade ultimately produces a stable fibrin clot, acting as a mesh to seal the vessel and prevent further blood loss.
This and much more—covering each coagulation factor and the chemical reactions that help prevent bleeding—are featured on the WFH official e-learning platform.
On the platform you will also gain insight into the dedicated efforts of WFH to improve care and support for the bleeding disorders community!
Read Hemostasis Today, get more insights on Bleeding Disorders Community.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring